“With shareholder approval secured, we look forward to closing the acquisition and strengthening our spine portfolio with the addition of the coflex Interlaminar Stabilization device,” said RTI Surgical President and CEO Camille Farhat.
The coflex device is a minimally invasive solution designed for patients with moderate to severe lumbar spinal stenosis. It has received FDA premarket approval to be performed in conjunction with decompression.
The company announced intentions to acquire Paradigm Spine in late 2018 and anticipates closing the acquisition March 8.
More articles on orthopedic devices:
38 orthopedic devices receive FDA 510(k) clearance in February
RTI Surgical reports $71.2M in Q4 revenue & more: 10 device company notes
MIsonix names COO: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
